Clotting Factors: Drug Target Sites

 
Factor/Component also called Target
I Fibrinogen  
II Prothrombin Heparin (IIa); Warfarin (synthesis)
III Tissue Thromboplastin  
IV Calcium  
V Proaccelerin  
VII Proconvertin Heparin (VIIa); Warfarin (synthesis)
VIII Antihemophilic globulin (AHG)  
IX Christmas factor, plasma thromboplastin component (PTC) Heparin (IXa); Warfarin (synthesis)
X Stuart-Prower factor Heparin (IXa); Warfarin (synthesis)
XI Plasma thromboplastin antecedent (PTA)  
XII Hageman factor  
XIII Fibrin-stabilizing factor  
Proteins C and S

-------

Warfarin (synthesis)
Plasminogen

-------

Thrombolytic enzymes, aminocaproic acid

return to main menu

Coagulation and Fibrinolysis: Regulation

  • Regional blood coagulation must be discreet in order to:
    • not impair blood flow excessively
    • avoid disseminated clotting
  • Systems regulating coagulation:
    • Fibrin inhibition
    • Fibrinolysis

return to main menu

return to main menu

return to main menu

Primary Reference: O'Reilly, R.A. Drugs Used in Disorders of Coagulation, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 916-940
Handlin, R.I. Bleeding and Thrombosis, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 339-344.